The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome

被引:48
作者
Clarke, G [1 ]
Ryan, E [1 ]
O'Keane, JC [1 ]
Crowe, J [1 ]
MacMathuna, P [1 ]
机构
[1] Univ Coll Dublin, Dept Gastroenterol, Dublin 7, Ireland
关键词
colonic disease; cytokeratins; immunohistochemistry; micrometastases; neoplasia;
D O I
10.1097/00042737-200012050-00012
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives The objectives of this study were to examine the frequency of lymph node micrometastases detected by keratin immunohistochemistry and their relationship with survival behaviour. Methods A total of 133 consecutive patients staged as Duke's B, who had curative resection for colorectal cancer (CRC), comprised the study population. Patients who had died of a non-CRC-related cause or who became lost to follow-up were excluded, resulting in an amended population of 100. Study end-points were defined as disease-free survival of 5 years or CRC-related death. Paraffin-embedded lymph node sections were stained with a commercial cytokeratin antibody using a standard avidin-biotin technique. Results One quarter of subjects had micrometastases. Fifty-six per cent of subjects with positive lymph nodes had an adverse outcome, compared with 11% of subjects with negative nodes. A highly significant association was found between lymph node cytokeratin expression and mortality in both the univariate (log rank P = 0.0001) and multivariate (Cox proportional hazards P = 0.0123) analysis. Conclusions Lymph node micrometastases detected by this inexpensive and simple technique are significantly associated with mortality in Duke's B CRC. This technique may be used to select patients for adjuvant chemotherapy. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:549 / 552
页数:4
相关论文
共 21 条
[1]  
Adell G, 1996, EUR J SURG, V162, P637
[2]   CANCER STATISTICS, 1993 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T .
CA-A CANCER JOURNAL FOR CLINICIANS, 1993, 43 (01) :7-26
[3]  
COHEN AM, 1991, CANCER, V67, P1859, DOI 10.1002/1097-0142(19910401)67:7<1859::AID-CNCR2820670707>3.0.CO
[4]  
2-A
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]   RESTAGING OF COLORECTAL-CANCER BASED ON THE IDENTIFICATION OF LYMPH-NODE MICROMETASTASES THROUGH IMMUNOPEROXIDASE STAINING OF CEA AND CYTOKERATINS [J].
CUTAIT, R ;
ALVES, VAF ;
LOPES, LC ;
CUTAIT, DE ;
BORGES, JL ;
SINGER, J ;
DASILVA, JH ;
GOFFI, FS .
DISEASES OF THE COLON & RECTUM, 1991, 34 (10) :917-920
[7]  
DAVIDSON BR, 1990, CANCER-AM CANCER SOC, V65, P967, DOI 10.1002/1097-0142(19900215)65:4<967::AID-CNCR2820650424>3.0.CO
[8]  
2-Y
[9]   Adjuvant medical therapy for colorectal cancer [J].
DiazCanton, EA ;
Pazdur, R .
SURGICAL CLINICS OF NORTH AMERICA, 1997, 77 (01) :211-+
[10]   CYTOKERATIN-IMMUNOREACTIVE CELLS OF HUMAN LYMPH-NODES AND SPLEEN IN NORMAL AND PATHOLOGICAL CONDITIONS - AN IMMUNOCYTOCHEMICAL STUDY [J].
DOGLIONI, C ;
DELLORTO, P ;
ZANETTI, G ;
IUZZOLINO, P ;
COGGI, G ;
VIALE, G .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1990, 416 (06) :479-490